» Articles » PMID: 11413309

The Hemagglutinin of Canine Distemper Virus Determines Tropism and Cytopathogenicity

Overview
Journal J Virol
Date 2001 Jun 20
PMID 11413309
Citations 84
Authors
Affiliations
Soon will be listed here.
Abstract

Canine distemper virus (CDV) and measles virus (MV) cause severe illnesses in their respective hosts. The viruses display a characteristic cytopathic effect by forming syncytia in susceptible cells. For CDV, the proficiency of syncytium formation varies among different strains and correlates with the degree of viral attenuation. In this study, we examined the determinants for the differential fusogenicity of the wild-type CDV isolate 5804Han89 (CDV(5804)), the small- and large-plaque-forming variants of the CDV vaccine strain Onderstepoort (CDV(OS) and CDV(OL), respectively), and the MV vaccine strain Edmonston B (MV(Edm)). The cotransfection of different combinations of fusion (F) and hemagglutinin (H) genes in Vero cells indicated that the H protein is the main determinant of fusion efficiency. To verify the significance of this observation in the viral context, a reverse genetic system to generate recombinant CDVs was established. This system is based on a plasmid containing the full-length antigenomic sequence of CDV(OS). The coding regions of the H proteins of all CDV strains and MV(Edm) were introduced into the CDV and MV genetic backgrounds, and recombinant viruses rCDV-H(5804), rCDV-H(OL), rCDV-H(Edm), rMV-H(5804), rMV-H(OL), and rMV-H(OS) were recovered. Thus, the H proteins of the two morbilliviruses are interchangeable and fully functional in a heterologous complex. This is in contrast with the glycoproteins of other members of the family Paramyxoviridae, which do not function efficiently with heterologous partners. The fusogenicity, growth characteristics, and tropism of the recombinant viruses were examined and compared with those of the parental strains. All these characteristics were found to be predominantly mediated by the H protein regardless of the viral backbone used.

Citing Articles

Canine Distemper Virus in Sardinia, Italy: Detection and Phylogenetic Analysis in Foxes.

Coradduzza E, Stefania F, Pintus D, Ferretti L, Ledda A, Chessa G Animals (Basel). 2024; 14(21).

PMID: 39518857 PMC: 11545482. DOI: 10.3390/ani14213134.


Safety and Immunogenicity of Vaccines for Domestic and Wild Animals: A Scoping Review.

Rendon-Marin S, Higuita-Gutierrez L, Ruiz-Saenz J Viruses. 2024; 16(7).

PMID: 39066240 PMC: 11281360. DOI: 10.3390/v16071078.


Universal peptide-based potential vaccine design against canine distemper virus (CDV) using a vaccinomic approach.

Rendon-Marin S, Ruiz-Saenz J Sci Rep. 2024; 14(1):16605.

PMID: 39026076 PMC: 11258135. DOI: 10.1038/s41598-024-67781-5.


A Bacterium-like Particle Vaccine Displaying Envelope Proteins of Canine Distemper Virus Can Induce Immune Responses in Mice and Dogs.

Liu L, Wang J, Li R, Wu J, Zhao Y, Yan F Viruses. 2024; 16(4).

PMID: 38675892 PMC: 11055036. DOI: 10.3390/v16040549.


Study of Canine Distemper Virus Presence in Catalonia's Wild Carnivores through H Gene Amplification and Sequencing.

Huang J, Cortey M, Darwich L, Griffin J, Obon E, Molina R Animals (Basel). 2024; 14(3).

PMID: 38338078 PMC: 10854788. DOI: 10.3390/ani14030436.


References
1.
Stephensen C, Welter J, Thaker S, Taylor J, Tartaglia J, Paoletti E . Canine distemper virus (CDV) infection of ferrets as a model for testing Morbillivirus vaccine strategies: NYVAC- and ALVAC-based CDV recombinants protect against symptomatic infection. J Virol. 1997; 71(2):1506-13. PMC: 191207. DOI: 10.1128/JVI.71.2.1506-1513.1997. View

2.
Meyers G, Tautz N, Becher P, Thiel H, Kummerer B . Recovery of cytopathogenic and noncytopathogenic bovine viral diarrhea viruses from cDNA constructs. J Virol. 1996; 70(12):8606-13. PMC: 190953. DOI: 10.1128/JVI.70.12.8606-8613.1996. View

3.
Schlereth B, Rose J, Buonocore L, Ter Meulen V, Niewiesk S . Successful vaccine-induced seroconversion by single-dose immunization in the presence of measles virus-specific maternal antibodies. J Virol. 2000; 74(10):4652-7. PMC: 111985. DOI: 10.1128/jvi.74.10.4652-4657.2000. View

4.
Welter J, Taylor J, Tartaglia J, Paoletti E, Stephensen C . Vaccination against canine distemper virus infection in infant ferrets with and without maternal antibody protection, using recombinant attenuated poxvirus vaccines. J Virol. 2000; 74(14):6358-67. PMC: 112142. DOI: 10.1128/jvi.74.14.6358-6367.2000. View

5.
Tao T, Skiadopoulos M, Davoodi F, Riggs J, Collins P, Murphy B . Replacement of the ectodomains of the hemagglutinin-neuraminidase and fusion glycoproteins of recombinant parainfluenza virus type 3 (PIV3) with their counterparts from PIV2 yields attenuated PIV2 vaccine candidates. J Virol. 2000; 74(14):6448-58. PMC: 112153. DOI: 10.1128/jvi.74.14.6448-6458.2000. View